Results 131 to 140 of about 6,026 (204)

Cefiderocol Elimination During Peritoneal Dialysis: A Short Report. [PDF]

Cureus
Müller-Kühnle J, Rittershofer B, Schanz M, Allgäuer S, Muerdter T, Schricker S.   +5 more
europepmc   +1 more source

Cefiderocol Sulfate Tosylate

American Journal of Health-System Pharmacy, 2020
openaire   +1 more source

Reply: NDM-producing Multidrug-resistant <i>Pseudomonas aeruginosa</i> in Korea: A Growing Threat Requiring National Attention. [PDF]

Infect Chemother
Kim T, Chong YP.
europepmc   +1 more source

Comparative effectiveness of antimicrobial regimens for pneumonia caused by drug-resistant Acinetobacter baumannii: a network meta-analysis including cefiderocol and inhaled therapies. [PDF]

BMC Infect Dis
Ai MY, Chang WL.
europepmc   +1 more source

The Achilles' heel of the Trojan Horse? A systematic evaluation of cefiderocol susceptibility testing. [PDF]

J Antimicrob Chemother
Tsakri D, Ferous S, Baltas I, Grandjean L, Anastassopoulou C, Tsakris A.   +5 more
europepmc   +1 more source

Genetic and phenotypic characterization of the plasmid-encoded NDM-80 metallo-β-lactamase in <i>Escherichia coli</i> isolated from a pediatric patient. [PDF]

Front Microbiol
Zhou J, Meng Q, Fan Q, Yang W, Ding L, Guo Y, Hu F, Lu G, Yan G.   +8 more
europepmc   +1 more source

Novel Insights into Carbapenem Resistance: Mechanisms, Diagnostics, and Future Directions. [PDF]

Antibiotics (Basel)
Miftode IL, Radu VD, Jigoranu RA, Leca DA, Prepeliuc CS, Pasare MA, Miftode RS, Grigoriu MG, Parângă TG, Miftode EG.   +9 more
europepmc   +1 more source

Cefiderocol as a Successful Therapy for Osteomyelitis Due to XDR <i>Pseudomonas aeruginosa</i>: A Case Report and Literature Review. [PDF]

Antibiotics (Basel)
Mulè A, Cambianica A, Matteelli A, Lorenzotti S, Lenzi A, Rossini F, Sollima A, Capone S, Castelli F.   +8 more
europepmc   +1 more source